Edition:
United States

Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

12.23USD
15 Dec 2017
Change (% chg)

$-0.18 (-1.45%)
Prev Close
$12.41
Open
$12.42
Day's High
$12.86
Day's Low
$12.07
Volume
3,178,349
Avg. Vol
831,363
52-wk High
$14.47
52-wk Low
$3.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 0.69 -0.969
FY 2017 Jun '17 0.64 -0.485
Mar '17 1.32 -0.550
Dec 0.38 -0.234
Sep 0.74 -0.169
FY 2016 Jun '16 0.93 -0.167
Mar '16 0.90 -0.148
Dec 0.67 -0.145
Sep 0.73 -0.163
FY 2015 Jun '15 2.40 -0.132
Mar '15 1.18 -0.126
Dec 1.00 -0.123
Sep 1.07 -0.133
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-17 3 2.33 5.50 0.60 --
Quarter Ending Sep-18 1 3.30 3.30 3.30 --
Year Ending Jun-17 3 4.77 8.00 3.00 --
Year Ending Jun-18 3 14.87 38.70 2.60 50.70
Year Ending Jun-19 3 35.47 60.90 13.00 --
Earnings (per share)
Quarter Ending Jun-17 3 -0.12 -0.10 -0.16 --
Quarter Ending Sep-18 1 0.19 0.19 0.19 --
Year Ending Jun-17 3 -1.07 -1.06 -1.10 --
Year Ending Jun-18 3 -1.07 -0.70 -1.35 -0.26
Year Ending Jun-19 3 -0.25 0.75 -0.84 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta 1.47 0.82 0.91
Price to Sales (TTM) 611.59 122.78 5.95
Price to Book (MRQ) -- 23.45 5.68
Price to Tangible Book (MRQ) -- 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 79.98 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg 0.00 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -6.92 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -6.30 29.98 5.62
Sales - 5 Yr. Growth Rate -37.62 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -473.58 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -255.61 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate 26.46 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.74 1.79 2.55
Current Ratio (MRQ) 0.74 5.62 3.56
LT Debt to Equity (MRQ) -- 16.22 13.38
Total Debt to Equity (MRQ) -- 18.71 19.38
Interest Coverage (TTM) -11.56 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 90.21 44.18 54.91
Gross Margin - 5 Yr. Avg. 85.27 55.78 52.46
EBITD Margin (TTM) -2,792.51 -- --
EBITD - 5 Yr. Avg -950.32 -215.66 15.63
Operating Margin (TTM) -3,250.26 -642.63 6.56
Operating Margin - 5 Yr. Avg. -900.69 -232.87 11.00
Pre-Tax Margin (TTM) -8,413.94 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -1,202.66 -233.04 11.41
Net Profit Margin (TTM) -8,414.63 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -1,183.71 -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 22,029 22,314,532 851,801,741
Net Income/Employee (TTM) -1,853,620 -1,997,855 99,542,701
Receivable Turnover (TTM) 6.01 26.15 6.13
Inventory Turnover (TTM) 0.69 2.62 3.56
Asset Turnover (TTM) 0.03 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -263.75 -9.39 11.31
Return on Assets - 5 Yr. Avg. -85.73 0.28 12.28
Return on Investment (TTM) -- -11.76 14.43
Return on Investment - 5 Yr. Avg. -119.48 3.42 16.07
Return on Equity (TTM) -- -36.72 16.01
Return on Equity - 5 Yr. Avg. -4,597.47 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -4.39 -30.08 -37.62
EPS (TTM) % -135.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immunomedics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 81.04%
# of Holders: 211
Total Shares Held: 123,193,934
3 Mo. Net Change: 26,365,726
# New Positions: 37
# Closed Positions: 15
# Increased Positions: 112
# Reduced Positions: 69
# Net Buyers: 43
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.